علاج الالتهاب الرئوي المرتبط بالتنفس الاصطناعي الناجم عن مسبب مرضي مقاوم للكاربابينيم وحساس للبوليميكسينات فقط

References

DOI: 10.1093/cid/ciw353

• In patients with HAP/VAP caused by a carbapenem-resistant pathogen that is sensitive only to polymyxins, we recommend intravenous polymyxins (colistin or polymyxin B) (strong recommendation, moderate-quality evidence), and we suggest adjunctive inhaled colistin (weak recommendation, low-quality evidence).
• For patients with VAP, we recommend a 7-day course of antimicrobial therapy rather than a longer duration (strong recommendation, moderate-quality evidence).